SEC Form 4 · accession 0001127602-18-033651
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lourdes Weltzien
Officer — EVP, Life Science
Period of report
Nov 15, 2018
Accepted (ET)
Nov 19, 2018 · 12:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 15, 2018 | A | 12,500 | $0.00 | A | 49,185 | D | |
| Common Stock | Nov 16, 2018 | F | 608 | $19.15 | D | 48,577 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units are awarded under the 2012 Stock Incentive Plan and vest in full (100%) on November 15, 2021.